Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 4;40(1):64.
doi: 10.1007/s10103-025-04319-9.

Photobiomodulation of gut microbiota with low-level laser therapy: a light for treating neuroinflammation

Affiliations
Review

Photobiomodulation of gut microbiota with low-level laser therapy: a light for treating neuroinflammation

Larissa Espindola da Silva et al. Lasers Med Sci. .

Abstract

The gut microbiota is known to interact with various organs in the body, including the central nervous system, through the gut-brain axis. Intestinal dysbiosis can lead to increased peripheral inflammation and, consequently, affect the brain, resulting in neuroinflammation. Photobiomodulation (PBM) has demonstrated positive regulatory effects on the imbalance of certain body functions, including pain, inflammation, immunity, wound healing, and gut microbiota dysbiosis. Therefore, PBM at the intestinal level could help improve intestinal dysbiosis and reestablish cerebral homeostasis. In this context, this study aimed to conduct a narrative review of the literature on the effects of PBM at the intestinal level on intestinal dysbiosis and neuroinflammation. Overall, the findings highlight that PBM modulates the gut microbiota, suggesting it could serve as a therapy for neurological conditions affecting the gut-brain axis. Future research should focus on further elucidating the molecular mechanisms underlying this therapy.

Keywords: Gut microbiota; Laser therapy; Neuroinflammation; Photobiomodulation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests. Informed consent: Not applicable.

References

    1. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG (2015) The infant microbiome development: mom matters. Trends Mol Med 21:109–117. https://doi.org/10.1016/J.MOLMED.2014.12.002 - DOI - PubMed
    1. Huttenhower C, Gevers D, Knight R et al (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. https://doi.org/10.1038/nature11234 - DOI
    1. Rutsch A, Kantsjö JB, Ronchi F (2020) The gut-brain Axis: how microbiota and host Inflammasome Influence Brain Physiology and Pathology. Front Immunol 11:604179. https://doi.org/10.3389/FIMMU.2020.604179 - DOI - PubMed - PMC
    1. Uchimura Y, Fuhrer T, Li H, Lawson MA, Zimmermann M, Yilmaz B, Zindel J, Ronchi F, Sorribas M, Hapfelmeier S, Ganal-Vonarburg SC, Gomez de Agüero M, McCoy KD, Sauer U, Macpherson AJ (2018) Antibodies set boundaries limiting Microbial Metabolite Penetration and the resultant mammalian host response. Immunity 49:545–559. https://doi.org/10.1016/J.IMMUNI.2018.08.004 - DOI - PubMed - PMC
    1. Keita AV, Söderholm JD (2010) The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22:718–733. https://doi.org/10.1111/J.1365-2982.2010.01498.X - DOI - PubMed

MeSH terms

LinkOut - more resources